DermTech Inc DMTK:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 04/15/24 EDT
0.62quote price arrow down-0.002 (-0.3215%)
Volume
97,507
52 week range
0.61 - 4.67
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.62
  • 52 Week High4.67
  • 52 Week High Date04/18/23
  • 52 Week Low0.61
  • 52 Week Low Date04/05/24

Key Stats

  • Market Cap21.467M
  • Shares Out34.62M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta2.54
  • YTD % Change-64.57

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.62
  • 52 Week High4.67
  • 52 Week High Date04/18/23
  • 52 Week Low0.61
  • 52 Week Low Date04/05/24
  • Market Cap21.467M
  • Shares Out34.62M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta2.54
  • YTD % Change-64.57

RATIOS/PROFITABILITY

  • EPS (TTM)-3.13
  • P/E (TTM)-0.20
  • Fwd P/E (NTM)-0.30
  • EBITDA (TTM)-101.933M
  • ROE (TTM)-106.46%
  • Revenue (TTM)15.296M
  • Gross Margin (TTM)1.80%
  • Net Margin (TTM)-659.57%
  • Debt To Equity (MRQ)0.10%

EVENTS

  • Earnings Date05/02/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On DermTech Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
DermTech, Inc. is a molecular diagnostic company. The Company is engaged in developing and marketing non-invasive genomics tests to aid in the diagnosis and management of melanoma. Its technology enhances evaluation of lesions suspicious for melanoma using non-invasive sample collection and detecting genomic markers associated with melanoma to identify higher risk lesions or rule out melanoma with a 99% or higher negative predictive value (NPV). It offers DermTech Melanoma...
Matthew Posard
Independent Chairman of the Board
Bret Christensen
President, Chief Executive Officer, Director
Kevin Sun
Chief Financial Officer, Treasurer, Secretary
Address
12340 EL CAMINO REAL
San Diego, CA
92130
United States

Top Peers

SYMBOLLASTCHG%CHG
AWH
Aspira Women's Health Inc
3.39-0.06-1.74%
BIOR
Biora Therapeutics Inc
0.62-0.051-7.6006%
ACON
Aclarion Inc
0.3061-0.0049-1.5854%
CNTG
Centogene NV
0.49-0.0655-11.7912%
XGN
Exagen Inc
1.43-0.05-3.38%